Coronavirus

Educate patients about how to purchase and store medical products without hoarding resources.

Individuals who have recovered from the initial disease are in generally poorer health later on compared with the general population, the analysis shows.

Aklilu Tedla, vice president of strategy and business development at Cardinal Health, discusses the cell and gene therapies in the pipeline for approval by the FDA.

Larger increases were typically seen in states with fewer deaths related to COVID-19, lower unemployment among women, analysis finds.

Baricitinib (Olumiant) approved for the treatment of adult patients hospitalized with COVID-19 who require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.

Second analysis indicates that parents of children with food allergies became less anxious during the pandemic.

Individuals who are not vaccinated with pre-existing diabetes, heart artery disease, or high blood pressure had a 2- to 3-fold increased risk of death, investigators say.

Findings show that key factors include age, infecting variant, underlying illnesses, and vaccination status.

FDA action was based on an analysis for the risk of thrombosis with thrombocytopenia syndrome, a rare and potentially life-threatening condition that causes blood clots combined with low levels of blood platelets.

This combination improves patient outcomes of vaccine-induced thrombotic thrombocytopenia after a COVID-19 vaccination, according to the results of a case analysis.

Although COVID-19 paused our original plans, we were ultimately able to reach more people than we ever could have via in-person presentations alone.

A panel of experts at the Asembia 2022 Specialty Pharmacy Summit discussed some of the obstacles in providing medications approved under Emergency Use Authorization.

For COVID-19 to turn into an endemic, there are a few criteria that must be met.

Study shows that the vaccine candidate demonstrated superior neutralizing antibody titers over the control, Vaxzevria from AstraZeneca.

Patients want more out of community pharmacies in a post-pandemic culture.

An overview for community pharmacies of a process to minimize vaccine errors using a COVID-19 vaccine point of distribution as an example.

Data from the study shows a strong immune response in this age group following this dose, with no new safety signals.

Hogue is the second pharmacist to ever serve on the advisory committee.

Individuals with diabetes, a higher body mass index, or a history of hospitalization are more likely to develop the condition, the analysis shows.

Evusheld concentrations remained elevated in serum for 6 months after administration, supporting that a single dose could provide long-term protection against COVID-19.

Almost all the participants who had not had COVID-19 seroconverted after vaccination, meaning they made antibodies against the virus.

Of the 53 pediatric patients enrolled in the CARAVAN study, no new safety signals were apparent for patients treated with remdesivir.

The PREVENT-19 study evaluates the immunogenicity and safety of a third dose of NVX-CoV2373 in children aged 12 to 17 years.

COVID-19 is associated with longer stays in the intensive care unit, which costs nearly twice as much to treat.

ARCT-154 demonstrates 95% efficacy overall for prevention of severe disease, including related deaths.

Depression can make people who have recovered from COVID-19 feel less enthusiastic in their daily lifestyle.

The booster vaccine candidate includes mutations found in the Beta variant of concern, several of which have been persistent in more recent variants such as the Omicron variant.

The CIC is a combination of Novavax’s COVID-19 vaccine, NVX-CoV2373, and its quadrivalent influenza vaccine candidate.

Each time a pharmacist immunizes a patient against one of the 27 infections for which a safe and effective vaccine exists, the profession continues to protect communities against diseases that wreaked havoc on generations.

Evusheld has been found to significantly reduce the risk of developing symptomatic COVID-19.